Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02345811 · ClinicalTrials.gov registry record · NA

A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT02345811: Completed NA study, sponsored by CooperVision.

NCT02345811 is a NA study that has completed, run by CooperVision. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02345811, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.

Primary Outcome

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Interventions

  • DEVICE senofilcon A
  • DEVICE Sapphire

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2015-01
Est. Completion 2015-03
Phase NA
CooperVision

64 total trials

What the finished NCT02345811 record still lists

NCT02345811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.

NCT02345811 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02345811 about?

NCT02345811 is a clinical study titled "A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks". To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.

What is the current status of trial NCT02345811?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-01. Estimated completion is 2015-03.

What interventions are being tested in trial NCT02345811?

The interventions under investigation include: senofilcon A (DEVICE), Sapphire (DEVICE).

Who is sponsoring clinical trial NCT02345811?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02345811's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02345811, the US trial registry maintained by the National Library of Medicine. NCT02345811 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.